BioScience Health InnovationsBHIC -0.80%45 Days Inventory is 208.33 as of Mar. 2026, which is 537% above its 10-year median of 32.69. GuruFocus rates BHIC with a GF Score™ of 45/100 and a GF Value™ of $164.84 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 495 Healthcare Providers & Services companies, BioScience Health Innovations ranks worse than 76.77% on this metric.
The historical rank and industry rank for BioScience Health Innovations's Days Inventory or its related term are showing as below:
BHIC'
s Days Inventory Range Over the Past 10 Years
Min: 29.37 Med: 32.69 Max: 121.67
Current: 74.56
During the past 7 years, BioScience Health Innovations's highest Days Inventory was 121.67. The lowest was 29.37. And the median was 32.69.
BHIC's Days Inventory is ranked worse than 76.77% of 495
companies
in the Healthcare Providers & Services industry
Industry Median: 30.42
vs BHIC: 74.56
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
BioScience Health Innovations's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioScience Health Innovations's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.81.
BioScience Health Innovations (OTCPK:BHIC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
BioScience Health Innovations's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioScience Health Innovations's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
BioScience Health Innovations Days Inventory Related Terms
BioScience Health Innovations Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioScience Health Innovations Days Inventory Chart
BHIC vs SHFH, PETS, SCNX: Days Inventory Comparison
For the Pharmaceutical Retailers subindustry, BioScience Health Innovations's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioScience Health Innovations Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, BioScience Health Innovations's Days Inventory distribution charts can be found below:
* The bar in red indicates where BioScience Health Innovations's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioScience Health Innovations (BHIC) has a Days Inventory of 208.33 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioScience Health Innovations and its competitors. This is 537% above median its historical median of 32.69. Over the past decade, BioScience Health Innovations' Days Inventory has ranged from 29.37 to 121.67. According to the industry distribution chart, BioScience Health Innovations ranks #380 out of 495 companies in the Healthcare Providers & Services industry, placing it in the top 76.8%.
Is BioScience Health Innovations' Days Inventory too high?
BioScience Health Innovations' current Days Inventory of 208.33 is 537% above median its 10-year median of 32.69. Over the past 10 years, this metric has ranged from a low of 29.37 to a high of 121.67. The Healthcare Providers & Services industry median Days Inventory is 30.42. BioScience Health Innovations' value of 208.33 is 584.8% above this industry median. Based on the distribution chart, BioScience Health Innovations ranks #380 out of 495 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, BioScience Health Innovations has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioScience Health Innovations' Days Inventory compare to SHFH and PETS?
According to the Healthcare Providers & Services industry distribution chart, BioScience Health Innovations ranks #380 out of 495 companies for Days Inventory. This places BioScience Health Innovations in the lower half of its industry. The industry median Days Inventory is 30.42. BioScience Health Innovations' value of 208.33 is 584.8% above this benchmark. Historically, BioScience Health Innovations' own Days Inventory has ranged from 29.37 to 121.67 over the past decade. While the company's 10-year median is 32.69 vs. the industry median of 30.42, BioScience Health Innovations has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 30.42, based on 495 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioScience Health Innovations's current Days Inventory of 208.33 is 584.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on BioScience Health Innovations and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 30.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioScience Health Innovations's current Days Inventory is 208.33, which is 537% above median its own 10-year median of 32.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioScience Health Innovations stock overvalued right now?
Based on GuruFocus' analysis, BioScience Health Innovations (BHIC) is currently considered Possible Value Trap. The stock's GF Value™ is $164.84, compared to a current price of $4.22 — trading 97.4% below its estimated fair value. The current Days Inventory is 208.33, which is 537% above median its 10-year median of 32.69 and 584.8% above the Healthcare Providers & Services industry median of 30.42. BioScience Health Innovations' overall GF Score™ is 45/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For BioScience Health Innovations (BHIC), the current Days Inventory is 208.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioScience Health Innovations (BHIC) Overvalued in 2026?
Based on GuruFocus' analysis, BioScience Health Innovations stock appears to be undervalued.
The current stock price of $4.22 is trading 97.4% below its estimated GF Value™ of $164.84.
GuruFocus considers BioScience Health Innovations to be Possible Value Trap.
Key valuation signals for BHIC:
Days Inventory: 208.33 (537% above median its 10-year median of 32.69)
GF Value™: $164.84 vs. price of $4.22 (97.4% below fair value)
Industry Position: 584.8% above the Healthcare Providers & Services median (#380 of 495)
No single metric tells the full story. See the BHIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioScience Health Innovations Business Description
BioScience Health Innovations Inc is engaged in full-scale operations as a distributor and generates revenue. The company's main business is to sell clinically tested, affordably priced products to naturally battle the onslaught of bacteria and viruses through online sales and various other distribution channels. The company develops, manufactures, and distributes science-backed nutritional supplements and delivery systems targeting cellular health, mitochondrial optimization, hormonal balance, and longevity.
45GF Score
Get the complete analysis for BHIC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHIC has been successfully added to your 
